Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * SITEMAP: /patient/sitemap.xml SITEMAP: |
Title | LUCENTIS® (ranibizumab) a Treatment Option for wAMD, DR & DME, mCNV, & |
Description | For Patients and Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more |
Keywords | N/A |
WebSite | lucentis.com |
Host IP | 104.18.27.56 |
Location | United States |
Site | Rank |
US$30,897,843
Last updated: 2023-05-04 13:18:02
lucentis.com has Semrush global rank of 342,558. lucentis.com has an estimated worth of US$ 30,897,843, based on its estimated Ads revenue. lucentis.com receives approximately 3,565,136 unique visitors each day. Its web server is located in United States, with IP address 104.18.27.56. According to SiteAdvisor, lucentis.com is safe to visit. |
Purchase/Sale Value | US$30,897,843 |
Daily Ads Revenue | US$28,522 |
Monthly Ads Revenue | US$855,633 |
Yearly Ads Revenue | US$10,267,591 |
Daily Unique Visitors | 237,676 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lucentis.com. | A | 299 | IP: 104.18.27.56 |
lucentis.com. | A | 299 | IP: 104.18.26.56 |
lucentis.com. | AAAA | 298 | IPV6: 2606:4700::6812:1a38 |
lucentis.com. | AAAA | 298 | IPV6: 2606:4700::6812:1b38 |
lucentis.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
lucentis.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
lucentis.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
lucentis.com. | MX | 3600 | MX Record: 10 aspmx3.googlemail.com. |
lucentis.com. | MX | 3600 | MX Record: 10 aspmx2.googlemail.com. |
lucentis.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
lucentis.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
lucentis.com. | TXT | 300 | TXT Record: v=spf1 a mx include:cmail1.com ?all |
lucentis.com. | TXT | 300 | TXT Record: rcn6q86mhfdwr28np9vkksvbyz711rlt |
lucentis.com. | TXT | 300 | TXT Record: google-site-verification=MzMhF_m8cevp5fauiponwZlKPVICFmV4Jw0dNFJqTaE |
Prescribing information Prescribing information Prescribing information Safety Safety MENU Prescribing information Safety LUCENTIS ® (ranibizumab injection) For Patients and Caregivers Wet age-related macular degeneration (wet AMD) Diabetic retinopathy and diabetic macular edema (DR and DME) Myopic choroidal neovascularization (mCNV) Macular edema following retinal vein occlusion (RVO) LUCENTIS ® (ranibizumab injection) For US Healthcare Professionals Wet age-related macular degeneration (wet AMD) Diabetic retinopathy and diabetic macular edema (DR and DME) Myopic choroidal neovascularization (mCNV) Macular edema following retinal vein occlusion (RVO) Learn more about your eye condition and how LUCENTIS may be able to help. Over 12 million doses have been given since 2006. Important Safety Information Back to Top Who is LUCENTIS for? LUCENTIS ® is a prescription medicine for the treatment of patients with: wet age-related macular degeneration (wAMD) diabetic retinopathy (DR) diabetic |
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 15:04:01 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Tue, 26 Oct 2021 16:04:01 GMT Location: https://lucentis.com/ Set-Cookie: __cfruid=b4d561e26f49b12e8736d132568da985a6ba9ce0-1635260641; path=/; domain=.lucentis.com; HttpOnly Server: cloudflare CF-RAY: 6a44931e3ec92a21-ORD HTTP/2 301 date: Tue, 26 Oct 2021 15:04:01 GMT content-type: text/html; charset=iso-8859-1 location: https://www.lucentis.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=b4d561e26f49b12e8736d132568da985a6ba9ce0-1635260641; path=/; domain=.lucentis.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a44931e9d586369-ORD HTTP/2 200 date: Tue, 26 Oct 2021 15:04:01 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=b4d561e26f49b12e8736d132568da985a6ba9ce0-1635260641; path=/; domain=.lucentis.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a44932128ea2d3a-ORD |
Domain Name: LUCENTIS.COM Registry Domain ID: 97224243_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2020-10-14T09:08:02Z Creation Date: 2003-04-25T19:18:49Z Registry Expiry Date: 2022-04-25T19:18:49Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T14:51:13Z <<< |